TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.

Sally Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.